intranasal glutathione in parkinson& 39 Innovative approach Parkinson's targeting via berberine-loaded mucoadhesive surface-modified liposomes: a multi-faceted study | BMC Pharmacology and Toxicology Parkinson's Disease: The Epidemiology, Risk
Parkinson's Disease: The Epidemiology, Risk Factors, Molecular Pathogenesis, Prevention, and Therapy PMC Frontiers Neuroinflammation in Parkinson's Disease Putative Pathomechanisms and Targets for Disease Modification Intranasal Delivery of Metabolically Resilient Glutathione: In Vivo Pharmacokinetic, Permeation, and Efficacy Studies Molecular Pharmaceutics Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson's Disease According to the Single Neuron Degeneration Model
Pay in 4 interest-free payments of $7.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



